Abstract
Purpose
to develop a procedure for registering changes, notifying users about changes made, unifying software as a medical device based on artificial intelligence technologies (SaMD-AI) changes, as well as requirements for testing and inspections—quality control before and after making changes.
Methods
The main types of changes, divided into two groups—major and minor. Major changes imply a subsequent change of a SaMD-AI version to improve efficiency and safety, to change the functionality, and to ensure the processing of new data types. Minor changes imply those that SaMD-AI developers can make due to errors in the program code. Three types of SaMD-AI testings are proposed to use: functional testing, calibration testing or control, and technical testing.
Results
The presented approaches for validation SaMD-AI changes were introduced. The unified requirements for the request for changes and forms of their submission made this procedure understandable for SaMD-AI developers, and also adjusted the workload for the Experiment experts who checked all the changes made to SaMD-AI.
Conclusion
This article discusses the need to control changes in the module of SaMD-AI, as innovative products influencing medical decision making. It justifies the need to control a module operation of SaMD-AI after making changes. To streamline and optimize the necessary and sufficient control procedures, a systematization of possible changes in SaMD-AI and testing methods was carried out.





References
He J, Baxter S, Xu J, Zhou X, Zhang K (2019) The practical implementation of artificial intelligence technologies in medicine. Nat Med 25:30–36. https://doi.org/10.1038/s41591-018-0307-0
Ranschaert E, Morozov S, Algra P (eds) (2019) Artificial intelligence in medical imaging. Springer, Cham
Gusev A, Dobridnyuk S (2017) Artificial intelligence in medicine and healthcare. Inform Soc 4–5:78–93
The World Health Organization guidance. Ethics and governance of artificial intelligence for health. https://www.who.int/publications/i/item/9789240029200
Sharova D, Zinchenko V, Akhmad E, Mokienko O, Vladzymyrskyy A, Morozov S (2021) On the issue of ethical aspects of the artificial intelligence systems implementation in healthcare. Dig Diagnost 2(3):356–368
Muller H, Mayrhofer M, Van Veen E, Holzinger A (2021) The ten commandments of ethical medical ai. Computer 54(7):119–123
Holzinger A, Malle B, Saranti A, Pfeifer B (2021) Towards multi-modal causability with graph neural networks enabling information fusion for explainable ai. Inform Fusion 71:28–37
Software as a Medical Device: Possible Framework for Risk Categorization and Corresponding Considerations: IMDRFSaMD WGN12FINAL:2014. http://www.imdrf.org/docs/imdrf/final/technical/imdrf-tech-140918-samd-framework-risk-categorization-141013.pdf
Larson D, Harvey H, Rubin D, Irani N, Tse J, Langlotz C (2020) Regulatory frameworks for development and evaluation of artificial intelligence-based diagnostic imaging algorithms: Summary and recommendations. J Am College of Radiol 18(3):413–424. https://doi.org/10.1016/j.jacr.2020.09.060
The United States Food and Drug Administration: Proposed Regulatory Framework for Modifications to Artificial Intelligence Machine Learning (AI ML)-Based Software as a Medical Device (SaMD) - Discussion Paper. https://www.fda.gov/media/122535/download (2019)
Morozov S, Vladzymyrskyy A, Ledikhova N, Andreychenko A, Arzamasov K, Balanjuk E, Gombolevskij V, Ermolaev S, Zhivodenko V, Idrisov I, Kirpichev J, Logunova T, Nuzhdina V, Omeljanskaja O, Rakovchen V, Slepushkina A (2020) Moscow experiment on computer vision in radiology: involvement and participation of radiologists. Phys Inform Technol 4:14–23
Experiment on the use of innovative computer vision technologies for analysis of medical images in the Moscow healthcare system. https://www.clinicaltrials.gov/ct2/show/NCT04489992 (2019)
Morozov S (2021) With the unified radiological information system (uris), the moscow health care department has laid the foundations for connected care. Health Manag org 21(6):348–351
Andreychenko A, Logunova T, Gombolevskiy V, Nikolaev A, Vladzymyrskyy V, AV abd Sinitsyn SP M (2022) A methodology for selection and quality control of the radiological computer vision deployment at the megalopolis scale. medRxiv 02(12):22270663 . https://doi.org/10.1101/2022.02.12.22270663
Order No. 160 of 2022 ‘On approving the Procedure and conditions for conducting the Experiment on the application of innovative computer vision technologies for the analysis of medical images and further use in the Moscow healthcare system in 2022’, paragraph 3
Andreychenko A, Gombolevskiy V, Vladzymyrskyy A, Morosov S (2021) How to select and fine-tune an AI service for practical application of radiology. Book of Abstract Eur Cong Radiol RPS, pp. 3–7
Sculley D, Holt G, Golovin D, Davydov E, Phillips T (2015) Hidden technical debt in machine learning systems. NIPS’15: Proceedings of the 28th International Conference on Neural Information Processing Systems 2:2503–2511
Regulation (Eu) 2017745 The European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 200183EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90385EEC and 9342EEC. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20200424
Pavlov N, Andreychenko A, Vladzymyrskyy A, Revazyan A, Kirpichev Y, Morozov S (2020) Reference medical datasets mosmeddata for independent external evaluation of algorithms based on artificial intelligence in diagnostics. Dig Diagnost 2(1):49–65
Morozov S, Vladzymyrskyy A, Klyashtornyy V, Andreychenko A, Kulberg N, Gombolevsky V, Sergunova K (2019) Clinical acceptance of software based on artificial intelligence technologies (radiology) vol. 57, p. 45. Best practices in medical imaging, Moscow . https://mosmed.ai/documents/35/CLINICAL_ACCEPTANCE_19.02.2020_web__1_.pdf
Carrington A, Fieguth P, Qazi H, Holzinger A, Chen H, Mayr F, Manuel D (2020) A new concordant partial auc and partial c statistic for imbalanced data in the evaluation of machine learning algorithms. BMC Med Inform Decis Mak (20(4)), 1–12
Software as a Medical Device (SaMD): Clinical Evaluation: IMDRFSaMD WGN41FINAL:2017. https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-170921-samd-n41-clinical-evaluation_1.pdf
IEC 62304:2006 Medical device software – Software life cycle processes
ISO 14971:2019 Medical devices – Application of risk management to medical devices
DIN SPEC 92001-1 Artificial intelligence - Life cycle processes and quality requirements - Part 1: Quality Meta Model
ISO/IEC TR 29119-11:2020 Software and systems engineering – Software testing – Part 11: Guidelines on the testing of AI-based systems
Health Science Authority: Regulatory Guidelines for Software Medical Devices – A Lifecycle Approach. https://www.hsa.gov.sg/docs/default-source/announcements/regulatory-updates/regulatory-guidelines-for-software-medical-devices--a-lifecycle-approach.pdf
Higgins D (2021) Onramp for regulating artificial intelligence in medical products. Adv Intell Syst 3:2100042
Collins G, Dhiman P, Andaur Navarro C, Ma J, Hooft L, Reitsma J, Logullo P, Beam A, Peng L, Van Calster B, van Smeden M, Riley R, Moons K (2021) Protocol for development of a reporting guideline (tripod-ai) and risk of bias tool (probast-ai) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open 11:048008
Sounderajah V, Ashrafian H, Golub R, Shetty S, De Fauw J, Hooft L, Moons K, Collins G, Moher D, Bossuyt P, Darzi A, Karthikesalingam A, Denniston A, Mateen B, Ting D, Treanor D, King D, Greaves F, Godwin J, Pearson-Stuttard J, Harling L, McInnes M, Rifai N, Tomasev N, Normahani P, Whiting P, Aggarwal R, Vollmer S, Markar S, Panch T, Liu X (2021) On behalf of the stard-ai steering committee. developing a reporting guideline for artificial intelligence-centred diagnostic test accuracy studies: the stard-ai protocol. BMJ Open (11), 047709
Liu X, Rivera S, Moher D, Calvert M, Denniston A, Ashrafian H, Beam A, Chan A, Collins G, Darzi A, Deeks J, ElZarrad M, Espinoza C, Esteva A, Faes L, Ferrante di Ruffano L, Fletcher J, Golub R, Harvey H, Haug C, Holmes C, Jonas A, Keane P, Kelly C, Lee A, Lee C, Manna E, Matcham J, McCradden M, Monteiro J, Mulrow C, Oakden-Rayner L, Paltoo D, Panico M, Price G, Rowley S, Savage R, Sarkar R, Vollmer S, Yau C (2020) Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the consort-ai extension. Nat Med 26:1364–1374
Omoumi P, Ducarouge A, Tournier A, Harvey H, Kahn CJ, Louvet-de Verchère F, Pinto Dos Santos D, Kober T, Richiardi J (2021) To buy or not to buy-evaluating commercial ai solutions in radiology (the eclair guidelines). Eur Radiol 31:3786–3796
Cabitza F, Campagner A (2021) The need to separate the wheat from the chaff in medical informatics: introducing a comprehensive checklist for the (self)-assessment of medical ai studies. Int J Med Inform 153:104510
Decision of the Board of the Eurasian Economic Commission No.174 dated December 22, 2015 On approval of the rules for monitoring the safety, quality and effectiveness of medical devices
European Union: Annual report on European SMEs. https://op.europa.eu/en/publication-detail/-/publication/cadb8188-35b4-11ea-ba6e-01aa75ed71a1/language-en (2018-2019)
Acknowledgements
A. Gusev, A. Maltsev., A. Gaidukov, D. Sharova and other members of SC01 “Artificial Intelligence in Healthcare”.
Funding
This study was funded by No. in the Unified State Information System for Accounting of Research, Development, and Technological Works (EGISU): AAAA-A21-121012290079-2 under the Program of the Moscow Healthcare Department “Scientific Support of the Capital’s Healthcare” for 2020–2022.
Author information
Authors and Affiliations
Contributions
Andreychenko A.E., Vladzymyrskyy A.V., and Morozov S.P. contributed to conceptualization and methodology. Chetverikov S.F. and Arzamasov K.M. performed the SAMD-AI tests. Zinchenko V.V., Chetverikov S.F., and Akhmad E.S contributed to analysis and writing—original draft preparation. Andreychenko A.E., Arzamasov K.M., Vladzymyrskyy A.V., and Morozov S.P. contributed to writing—review and editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare they have no financial interests. Morozov S.P. was an unpaid president European Society of Medical Imaging Informatics (till 2018). Morozov S.P. is an unpaid chairman of SC 01 “Artificial Intelligence in Healthcare”.
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
For this type of study formal consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendices
Appendix A The list of abbreviations
CT - Computed tomography
CTT - Control and technical testing
LDCT - Low-dose computed tomography
ROC - Receiver operating characteristic
SaMD-AI - a Software as a medical device based on artificial intelligence technologies
URIS - Unified radiological information service
Appendix B Types of changes to AI services
Rights and permissions
About this article
Cite this article
Zinchenko, V., Chetverikov, S., Akhmad, E. et al. Changes in software as a medical device based on artificial intelligence technologies. Int J CARS 17, 1969–1977 (2022). https://doi.org/10.1007/s11548-022-02669-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11548-022-02669-1